ClinicalTrials.gov
public full text
Public Domain
Enalapril After Anthracycline Cardiotoxicity
To determine if the chronic administration of enalapril, an inhibitor of angiotensin converting enzyme (ACE), reduces progression of cardiac dysfunction in pediatric oncology patients who have received anthracyclines, and who are not currently on digoxin, diuretics, or vasodilators for heart failure.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cardioprotection in AML#1349477
- Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction#1057068
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)#1197779
- Allopurinol in Acute Coronary Syndrome#1259440
- Atorvastatin For The Reduction Of Ventricular Arrhythmias#911017
Record · ID 1365920
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive